Dottie Caplan works in Corporate Affairs for Sanofi. Back in May, Dottie took part in our Biotech 101 course. Here is what she had to say about the course.
Why did you decide to take Biotech 101?
The scientific advancements in biotechnology will dramatically change the healthcare landscape and, while I am not a scientist, it is critical to understand the fundamentals in order to make sense of what is happening in the industry and the implications these changes will have on the future healthcare environment.
What knowledge of biotech did you have before taking this course?
I knew bits and pieces of what is happening in the biotech world but I didn’t understand all the motivations and barriers or the strategic thinking and connectivity that would allow me to really be proactive. I am more confident and prepared to think more strategically about Biotech and what it means for the future.
What was your favorite part of the course?
The hands-on experiments really solidified the material and content of the course. The instructor was highly educated and informed and experienced the biotech world first hand. Being able to see biotech through her eyes and experience was invaluable.
What do you feel you gained from this course?
I am more strategic in my thinking and I can easily engage in a business discussion on biotech with confidence. I view events and news differently because I am able to more readily connect the dots with what is happening and understand the motivations behind the decision making and strategies being implemented.
What would you tell someone who was thinking about taking this course?
This is one of the best courses I have ever taken and you will not be disappointed. It is worth the investment of time and money. You would be hard-pressed to find a course of this caliber anywhere else.
There is still time to register for Biotech 101 on Dec 17th & 18th!
We have also announced our first spring course!
On November 21, MassBioEd worked with Google to host a STEM Expo Night as a Kendall Square Association Third Thursday networking event. The evening celebrated STEM education efforts in the Kendall Square community, featured many fun hands-on science experiments and drew a crowd of about 100 people.
Special thanks to all of our exhibitors, to Google for hosting and providing beverages, to KSA, and to Phoodeez for their generous catering donation!
Thank you to everyone who participated! Here are some of the activities that took place:
The MassBio & MassBioEd teams have plenty to give thanks for this holiday season.
We are thankful for a dynamic, inspiring community of scientists, life sciences leaders, policy leaders, and patient advocates. We are thankful for the work you do each day to ensure our family and friends can lead fuller, healthier lives.
We are thankful for your support of our initiatives as we strive to enhance the life sciences super-cluster so it continues to be an ecosystem that allows and encourages the the development of critical new science, technology and medicines that benefit people worldwide.
We are also thankful for your support of the MassBioEd Foundation and like-minded organizations committed to enhancing science and biotechnology education in Massachusetts and developing the life sciences workforce of the future.
We wish you and your families a happy, healthy Thanksgiving holiday!
MassBio and MassBioEd are looking forward to heading to the Massachusetts STEM Summit tomorrow! As we get ready to spend the day with STEM leaders throughout the Commonwealth, we thought we would share a bit here about Biotech Futures, one of MassBioEd’s STEM career exploration programs!
In October, students from the Charles H. McCann Technical School in North Adams and the Hampshire Regional High School in Westhampton participated in Biotech Futures, a career exploration event featuring science demonstrations and laboratory projects at Westfield State University.
The program, organized by MassBioEd Foundation is part of an ongoing effort to increase interest in careers in science, technology, engineering and math (STEM) fields. Biotech Futures events are held at colleges and universities throughout the state. Next week, MassBioEd is holding a Biotech Futures event at UMass Lowell (learn more here).
Over the course of two days, students from Charles H. McCann Technical School in North Adams and Hampshire Regional High School in Westhampton participated in Biotech Futures, a career exploration event featuring science demonstrations and laboratory projects at Westfield State University, according to a news release. Link
2) Shire’s ADHD drug succeeds in trial to treat binge eating- Reuters- November 5, 2013
Pharmaceutical group Shire PLC said Vyvanse, its amphetamine-based drug prescribed to U.S. students to control ADHD, had also been successful in treating the newly-recognized binge eating disorder (BED) in a trial. Link
3) Natick biotech Karyopharm raises $109m- Boston Globe- November 6, 2013
Shares of Karyopharm Therapeutics Inc., a four-year-old Natick company working on a drug that aids the body’s natural tumor-suppressing proteins, moved modestly higher in their first day of trading after the company raised $109 million in an initial public offering. Link
4) J&J innovation team sets up international collaboration to discover Alzheimer’s drugs- Fierce Biotech- November 8, 2013
Johnson & Johnson has spent hundreds of millions of dollars in a so-far failed effort to develop a late-stage biologic that could be used to treat Alzheimer’s. And it’s now prepared to spend hundreds of millions more as it goes back to the drawing board to explore the molecular underpinnings of the disease in an attempt to find new therapies that promise to thwart the disease before it cripples the brain. Link
5) Paris Panayiotopoulos is the new president and managing director of EMD Serono- Boston.com- November 8, 2013
Rockland-based EMD Serono Inc., a subsidiary of a German pharmaceutical, chemical, and life sciences company with nearly 900 employees in Massachusetts, announced the appointment Friday of Paris Panayiotopoulos as its president and managing director. Link